TheraRadar
← Back
Data updated: Jun 28, 2026

SCHERER RP

Generics
Pharmaceuticals

SCHERER RP is a generic drug manufacturer with 4 FDA-approved products.

1981
Since
4
Drugs
-
Trials
0
New Drugs (2yr)

SCHERER RP's Key Drugs

SCHERER RP's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

SCHERER RP's Recent FDA Approvals

New NDA/BLA approvals for SCHERER RP over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

SCHERER RP's Therapeutic Areas

Disease areas where SCHERER RP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

SCHERER RP Pipeline Snapshot

Active clinical trials for SCHERER RP across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling